There are 2789 resources available
855P - Exploring the cardio-cerebrovascular outcomes and thromboembolic risks among BCR-ABL1-negative myeloproliferative neoplasms treated with ruxolitinib: Systematic review and meta-analysis
Presenter: Boby Pratama Putra
Session: ePoster Display
856P - A comparison of the burden of leukemia amongst European Union 15+ countries, 1990-2019
Presenter: Chinmay Jani
Session: ePoster Display
867P - A phase I trial of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma
Presenter: Ari Rosenberg
Session: ePoster Display
869P - Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results of a pilot study
Presenter: Jennifer Johnson
Session: ePoster Display
870P - Comparison of PD-L1 and VISTA expression levels in head and neck cancers in primary and recurrent tumor tissue after radiotherapy/chemoradiotherapy
Presenter: Görkem Yazıcı Şener
Session: ePoster Display
871P - Uptake of concurrent chemoradiation in stage 2 nasopharyngeal cancer (NPC): A population-based outcomes study
Presenter: Teng Hwee Tan
Session: ePoster Display
738P - Quality-adjusted time without symptom or toxicity (QA-TWiST) and quality-adjusted progression-free survival (QA-PFS) of first-line (1L) maintenance niraparib in patients with advanced ovarian cancer (OC): Results from the PRIMA trial
Presenter: Maria-Pilar Barretina-Ginesta
Session: ePoster Display